Polen Capital latest buys and sells
37 new positions in Polen Capital's latest 13F filing, largest first. The largest is the new position in STX, $187.8M or 2.0% of the reported portfolio.
Key facts
- New positions
- 37
- Largest move
- STX, $187.8M
- Latest filing
- Nov 13, 2026
From Polen Capital Management's filing for (Q3 2026), filed , against the filing for Jun 30, 2026.
| # | Stock | Move | Shares | Size | Of portfolio |
|---|---|---|---|---|---|
| 1 | Seagate Technology HldngsSTX | ▲ New | +203.6K | $187.8M | 2.04% |
| 2 | Quanta Services IncPWR | ▲ New | +163.6K | $105.1M | 1.14% |
| 3 | SPDR Ser Trustno ticker on file | ▲ New | +128.14K | $29.6M | 0.32% |
| 4 | iShares Trustno ticker on file | ▲ New | +28.93K | $16.4M | 0.18% |
| 5 | iShares Global Tech ETFIXN | ▲ New | +105.68K | $15.7M | 0.17% |
| 6 | SK Hynix IncSKHY | ▲ New | +79.49K | $14.6M | 0.16% |
| 7 | iShares TrustIGV | ▲ New | +130.05K | $13.8M | 0.15% |
| 8 | SPDR Series TrustKCE | ▲ New | +73.99K | $11.4M | 0.12% |
| 9 | iShares Trustno ticker on file | ▲ New | +43.79K | $9.1M | 0.10% |
| 10 | Vanguard World FDVIS | ▲ New | +21.53K | $6.9M | 0.07% |
| 11 | iShares TrustIHI | ▲ New | +122.2K | $6.3M | 0.07% |
| 12 | Precigen IncPGEN | ▲ New | +697.15K | $6M | 0.06% |
| 13 | Xometry IncXMTR | ▲ New | +50.81K | $5.2M | 0.06% |
| 14 | Ascendis Pharma A/SASND | ▲ New | +21.86K | $5M | 0.05% |
| 15 | Marex Group LtdMRX | ▲ New | +70.41K | $4.9M | 0.05% |
| 16 | Maxlinear IncMXL | ▲ New | +51.32K | $4.6M | 0.05% |
| 17 | Hinge Health IncHNGE | ▲ New | +46.31K | $4.5M | 0.05% |
| 18 | Netskope IncNTSK | ▲ New | +236.72K | $4.1M | 0.04% |
| 19 | Materion CorpMTRN | ▲ New | +14.94K | $4M | 0.04% |
| 20 | Beta Technologies IncBETA | ▲ New | +178.27K | $3.9M | 0.04% |
| 21 | Alibaba Group Holding LtdBABA | ▲ New | +36.17K | $3.9M | 0.04% |
| 22 | iShares Trustno ticker on file | ▲ New | +32.1K | $3.8M | 0.04% |
| 23 | Digi International IncDGII | ▲ New | +49.55K | $3.8M | 0.04% |
| 24 | Brightspring Health Services IncBTSG | ▲ New | +55.25K | $3.1M | 0.03% |
| 25 | Oruka Therapeutics IncORKA | ▲ New | +36.27K | $3M | 0.03% |
| 26 | HeartFlowHTFL | ▲ New | +58.05K | $2.9M | 0.03% |
| 27 | Sellas Life Sciences GroupSLS | ▲ New | +218.09K | $2.7M | 0.03% |
| 28 | Fundvantage Trustno ticker on file | ▲ New | +117.26K | $2.6M | 0.03% |
| 29 | Vaneck ETF TrustSMH | ▲ New | +4.12K | $2.5M | 0.03% |
| 30 | Allied Motion Technologies IncALNT | ▲ New | +20.97K | $2.3M | 0.03% |
| 31 | Fundvantage Trustno ticker on file | ▲ New | +91.28K | $2.3M | 0.03% |
| 32 | MBX Biosciences IncMBX | ▲ New | +39.48K | $2.3M | 0.03% |
| 33 | Ryman Hospitality PropertiesRHP | ▲ New | +19.22K | $2.3M | 0.02% |
| 34 | Fastly IncFSLY | ▲ New | +83.24K | $2.1M | 0.02% |
| 35 | Pulse Biosciences IncPLSE | ▲ New | +42.14K | $2.1M | 0.02% |
| 36 | Andersen Group IncANDG | ▲ New | +38.57K | $2.1M | 0.02% |
| 37 | Invesco Exchange Traded FD Trust IIno ticker on file | ▲ New | +11.28K | $1.8M | 0.02% |
Questions and answers
What did Polen Capital buy last quarter?
The largest purchases in the latest 13F filing: STX, $187.8M; PWR, $105.1M; SPDR Ser Trust, $29.6M; iShares Trust, $16.4M; IXN, $15.7M; SKHY, $14.6M.
How is the size of a buy or sell worked out?
As the change in shares at the price the filing implies for the quarter's end (reported value divided by shares) — an estimate of the trade, not what was paid. A position sold out is sized at its value in the previous filing.
Learn
Cite this page
Funkfolio, “Polen Capital: buys and sells, Q3 2026 13F”, data as of 13 November 2026. https://funkfolio.com/gurus/activity?type=new&investor=polen-capital
Underlying data: SEC EDGAR, Form 13F-HR.
Source: SEC EDGAR, Form 13F-HR. A move is a change in share count between an investor's latest filing and the one before; a share split in between is allowed for where one is on record. Size is the shares bought or sold at the price the filing implies for the period end (reported value ÷ shares) — an estimate of the trade, not what was paid — and a position sold out is sized at its value in the previous filing. “Of portfolio” sets that size against the portfolio reported for the period. Only each investor's 150 largest positions and 50 largest exits are read. Filings appear up to 45 days after the quarter ends; none of this is advice.